Company Search:
Advanced Search
Sponsored Links
Valirx Plc Company Snapshot
Valirx Plc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Valirx Plc with three other companies in this sector in UNITED KINGDOM : Reneuron Group PLC (2015 sales of £30,000.00 [US$39,840.60 ] of which 100% was Cell-Based Therapies), Immupharma PLC (£76,407.00 [US$101,470.02 ] of which 100% was Pharmaceutical Research & Development), and Tissue Regenix Group PLC (£100,000.00 [US$132,802.00 ] of which 72% was BioSurgery).

Sales Analysis. Valirx Plc reported sales of £82,603.00 (US$109.70 thousand) for the year ending December of 2015. This represents a decrease of 5.7% versus 2014, when the company's sales were £87,558.00 .
  Stock Performance Chart for Valirx Plc
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 22.25p
(Figures in Pounds Sterling)
1 Week 12.7%   13 Weeks -8.2%  
4 Weeks 61.8%   52 Weeks 33.8%  
Valirx Plc Key Data:
  Ticker: VAL Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 82,603
(Year Ending Jan 2016).
Employees: 11
  Currency: Pounds Sterling Market Cap: 12,028,878
  Fiscal Yr Ends: December Shares Outstanding: 54,062,373
  Share Type: Ordinary Closely Held Shares: 13,219,886
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.